Asan Medical Center

Seoul, Korea 138-736

0 studies enrolling now · 7 studies all time

What they study most

Advanced Cancer, Biliary Tract Cancer, Biliary Tract Neoplasms, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Endometrial Neoplasms, Metastatic Cancer, Ovarian Neoplasms, Pancreatic Neoplasms, Rheumatoid Arthritis, Soft Tissue Sarcoma

Studies at this site

• A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer — Running, not enrolling
• Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) — Running, not enrolling
• A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma — Completed
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
• Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer — Completed